SLDB•globenewswire•
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Summary
CHARLESTOWN, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 7,000 restricted stock units (“RSUs”) to one newly hired employee.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 5, 2026 by globenewswire